Common Contracts
13 similar Executive Employment Agreement contracts by Sucampo Pharmaceuticals, Inc.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Jason Meyenburg (“Executive”), and amends, restates and supersedes in its entirety that certain employment letter agreement, dated December 3, 2016, between Executive and Vtesse Inc., now a wholly-owned subsidiary of Sucampo (the “Prior Agreement”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Pfreundschuh (“Executive”), and amends, restates and supersedes the Employment Agreement dated March 20, 2017 (the “Prior Agreement”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Matthew Maxwell Donley (“Executive”, and amends, restates and supersedes the Employment Agreement dated August 3, 2016 (the “Prior Agreement”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Dr. Peter Kiener (“Executive”), and amends, restates and supersedes the Employment Agreement dated August 2, 2016 (the “Prior Agreement”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Greenleaf (“Executive”), and amends, restates and supersedes the Employment Agreement dated August 3, 2016 (the “Prior Agreement”).
AMENDED & RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Jones Woodrow Bryan, Jr. (“Executive”), and amends, restates and supersedes the Employment Agreement dated March 7, 2017 (the “Prior Agreement”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 16th, 2018 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 2nd, 2017 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Jones Woodrow Bryan, Jr. (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 3rd, 2017 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Pfreundschuh (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Greenleaf (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated March 3, 2014.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Peter Kiener (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated October 21, 2014.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Andrew Smith (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated January 30, 2015.
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Sucampo Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Amended and Restated Executive Employment Agreement (the “Agreement”) is made by and between Sucampo Pharmaceuticals, Inc., its parent, subsidiary, predecessor and affiliated corporations (collectively “Sucampo”), and Matthew Maxwell Donley (“Executive”), and amends, restates and supersedes the Employment Agreement between Sucampo and Executive dated October 21, 2014.
